Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study

Details 詳細情報について

• CRID

  1363951795691657472

• DOI

  10.1111/j.1538-7836.2008.03054.x

• ISSN

  15387836

• Web Site

  https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1538-7836.2008.03054.x

  https://api.elsevier.com/content/article/PII:S1538783622120398?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1538783622120398?httpAccept=text/plain

  http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2008.03054.x/fullpdf

• Data Source

  • Crossref